News

News

7/23/2010 - Article on FGI's TSG101 Antibody published in American Journal of Translational Research

7/1/2010 - Functional Genetics Announces Two Separate Awards from the National Institute of Allergy and Infectious Diseases To Develop Broad Spectrum Antivirals

4/25/2010 - FGI's RHGP Featured in Analytical and Quantitative Cytology and Histology. 

4/19/2010 - Article on FGI 103 Small Molecule Published in Antimicrobial Agents and Chemotherapy, American Society for Microbiology.

11/23/2009 - The Gates Foundation Funds FGI for TSG101 Vaccine to Target HIV

11/11/2009 - FGI Discovers New Alzheimer's Disease Target Using RHGP
    Work Published in NEURON

9/29/2009 - FGI's Article on RHGP and Host-Oriented Targets for HIV Published in VIROLOGY JOURNAL

8/26/2009 - FGI's Paper on RHGP Reviewed by FACULTY OF 1000 BIOLOGY

8/21/2009 - FGI's Manuscript on Broad Spectrum Antiviral Activity published in ANTIVIRAL RESEARCH

8/17/2009 - FGI's Novel Approach Highlighted by NEW SCIENTIST magazine

6/4/2009 - FUTURE ONCOLOGY Publishes FGI's
"Function-First Approaches to Improve Target Identification in Cancer"

5/4/2009 - Functional Genetics Highlights Progress in the Development of Broad-Spectrum Antiviral at the 22nd International Conference on Antiviral Research.

12/9/2008 - Functional Genetics, Inc. Announces Agreement with Elanco, a Division of Eli Lilly and Company

11/12/2008 - Functional Genetics, Inc. And ProBioGen AG Close Antibody Production Agreement

4/8/2008 - Functional Genetics Inc. was profiled in Nature Biotechnology.

6/3/2007 - Functional Genetics, Inc. Receives Award to Discover New Opportunities to Combat HIV Infection

12/1/2006 - Functional Genetics, Inc. Announces Two Separate Awards from the
United States Defense Threat Reduction Agency (DTRA) to Combat Viral
Diseases